None

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow traded up 0.46% to 34,989.30 while the NASDAQ rose 0.16% to 14,116.28. The S&P 500 also rose, gaining, 0.26% to 4,507.40. Check This Out: Top 4 Energy Stocks That Are Preparing To Pump This Month   Leading and Lagging Sectors   Materials shares surged by 0.7% on Wednesday. In trading on Wednesday, utilities shares fell by 0.4%.   Top Headline   Shares of TJX Companies Inc (NYSE: TJX) fell on Wednesday after the company issued weak profit forecast for the fourth quarter. TJX reported third-quarter FY24 sales growth of 9% year-on-year to $13.3 billion, beating the analyst consensus estimate of $13.08 billion. EPS of $1.03 beat the consensus estimate of $0.99. For the fourth quarter, TJX said it now sees adjusted EPS between 97 cents and $1, down from its earlier forecast of between $1 and $1.03.   Equities Trading UP   AST SpaceMobile, Inc. (NASDAQ: ASTS) shares shot up 27% to $4.7750 following third-quarter results Shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) got a boost, shooting 61% to $0.8711 after the company reported mixed third-quarter financial results and issued guidance. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares were also up, gaining 32% to $0.8050 ...

Related tickers: TJX, HRTX, ASTS, CMMB, GLBE, SDOT, ELIQ.

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fell 20.8% to $2.36 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares climbed 62.4% to $2.16 after the company reported third-quarter results. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 55% to $0.9497 after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), a fibrotic liver disease. Heron Therapeutics, Inc. (NASDAQ: HRTX) climbed 50.8% to $0.8143 after the company reported mixed third-quarter financial results and issued guidance. Kinnate Biopharma Inc. (NASDAQ: KNTE) rose 47.7% to $2.32. The company’s board of directors received a letter from Foresite Capital Management and OrbiMed Advisors indicating their intent to explore and evaluate a potential acquisition of the company. SciSparc Ltd. (NASDAQ: SPRC) gained 44.5% to $6.30. SciSparc said 'trial results indicated that SciSparc's proprietary SCI-110 provided a safe and effective solution for alleviating agitation in elderly Alzheimer's patients who participated.' Evelo Biosciences, Inc. (NASDAQ: EVLO) gained 36% to $0.47. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) climbed 34.3% to $1.75. Solid Biosciences Inc. (NASDAQ: SLDB) shares rose 32.7% to $2.83. Solid Biosciences announced IND clearance by the FDA for duchenne muscular dystrophy gene therapy candidate SGT-003. MGO Global, Inc. (NASDAQ: MGOL) shares climbed 32.4% to $0.6566 after reporting a sharp rise in third-quarter sales. Beyond Air, Inc. (NASDAQ: XAIR) gained 28% to $1.7920. AST SpaceMobile, Inc. (NASDAQ: ASTS) rose 28% to $4.8262 following third-quarter results. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 25.2% to $24.34 after the company reported a ...

Related tickers: VWE, BTDR, IHRT, INTA, SXTP, AYTU, MNTS, AEY, SDOT, EVLO, ICVX, SGMO, ELIQ, ATOM, SHPW, ALC, EGOX, SLDB, VLCN, BW, GYRE, XAIR, MRAI, TGT, KBNT, SLNH, VFC, TSHA, TIVC, CRMD, KNTE, PRSO, TRIP, MYTE, SPRC, ARCT, ZIM, JGGC, INTZ, ASTS, HSCS, FTCH, CMMB, MGOL, CHGG, RBOT, ISPR, HRTX, TRKA, HRYU, DADA, GLBE.